What's new

Summary of opinion: Stelara Positive

Summary of opinion: Stelara Positive

Feb 28, 2025 - 13:43
 0
Summary of opinion: Stelara Positive
Summary of opinion: Stelara Positive
Read More

Tags:

Previous Article

First topical gene therapy treatment for dystrophic epidermolysis bullosa

Next Article

Summary of opinion: Imfinzi, 27/02/2025 Positive

Related Posts

Human medicines European public assessment report (EPAR): Zefylti, filgrastim, Date of authorisation: 12/02/2025, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 10, 2025  0

Conversations on cancer - cervical cancer treatment innovation: a collaborative discussion , European Medicines Agency, Amsterdam, the Netherlands, from 14 January 2025, 16:00 (CET) to 14 January 2025, 17:00 (CET)

Conversations on cancer - cervical cancer treatment inn...

Feb 14, 2025  0

Human medicines European public assessment report (EPAR): Biktarvy, bictegravir,emtricitabine,tenofovir alafenamide, Date of authorisation: 21/06/2018, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0